Inflammation, Tumoral Markers and Interleukin-17,-10, and-6 Profiles in Pancreatic Adenocarcinoma and Chronic Pancreatitis
DIGESTIVE DISEASES AND SCIENCES
Authors: Tantau, Alina; Leucuta, Daniel-Corneliu; Tantau, Marcel; Botan, Emil; Zaharie, Roxana; Mandrutiu, Alina; Tomuleasa, Ionut-Ciprian
Abstract
Background Interleukin profiles can be used as biochemical markers regarding the early diagnosis of pancreatic cancer. Aims To assess CRP, CA 19-9, CEA levels, and interleukin-6, -10, and -17 profiles in pancreatic ductal adenocarcinoma, chronic pancreatitis was compared with a control group, and the correlation with pancreatic cancer survival. Methods A total of 87 patients were prospective divided in pancreatic cancer (n = 53), chronic pancreatitis (n = 22) ,and control group (n = 12). The diagnosis of PDAC was made histologically. The diagnosis of chronic pancreatitis was based on medical history, imaging methods, and endoscopic ultrasound. Systemic concentrations of interleukins were measured using ELISA kits. The patients were followed at 1, 3, and 6 months. Results CRP, CA 19-9, and CEA were higher in the pancreatic cancer group (p < 0.001). Interleukin-10 was significantly higher in the pancreatic cancer and chronic pancreatitis groups (p < 0.001). Interleukin-17 was statistically higher in the pancreatic cancer group (p < 0.0001). The cut-off of interleukin-17 of 0.273 had a sensitivity of 90.9 and a specificity of 80.9 with a curve under ROC of 0.80 in order to differentiate between pancreatic cancer and chronic pancreatitis. The serum levels of interleukins are not correlated with the stage of the disease. CRP, CA 19-9, CEA, and interleukin-6, -10, and -17 were lower in patients with survival more than 6 months. Conclusions We detected high levels of interleukin-6, -10, and -17 in chronic pancreatitis and pancreatic cancer. Serum interleukin-17 levels can discriminate between pancreatic cancer and chronic pancreatitis. The prognostic role of interleukins needs to be established.
Laparoscopic Management of Peritonitis Due to a Ruptured Ovarian Endometrioma with Extremely High Levels of Cancer Antigen-125 and Cancer Antigen-19-9
JOURNAL OF GYNECOLOGIC SURGERY
Authors: Pandey, Deeksha; Wasinghon, Phornsawan; Huang, Kuan-Gen
Abstract
Background: An endometrioma is a common gynecologic condition, usually defined as a growth of endometrial tissue outside the uterine cavity. Rarely, an ovarian endometrioma can rupture spontaneously, while the clinical significance of serum cancer antigen (CA)-125 and CA-19-9 levels might be that they are indicators of the presence of that endometrioma. Case: A 23-year-old nulliparous woman had acute abdominal pain with peritonitis. Computed tomography showed a left ovarian mass similar to 12 cm with fluid collection in the intra-abdominal cavity and thickening of the omentum. These findings appeared to be ovarian cancer with ascites and omental caking. The patient's CA-125 and CA-19-9 levels were 25,149 U/mL and 5379 U/mL, respectively. Results: A laparoscopic view showed a ruptured left ovarian endometrioma with diffused chocolate content over the surface of the liver, omentum, and intra-abdominal cavity. Laparoscopic enucleation of the left ovary, peritoneal irrigation, and adhesiolysis were performed. A pelvic mass score, such as a risk of malignancy index, could not be used to detect malignant ovarian cancer due to the patient's high levels of CA-125 and CA-19-9. Conclusions: High-combination CA-125 and CA-19-9 concentrations could indicate the presence of a ruptured endometrioma. Laparoscopy-performed by an experienced endoscopist-is an efficient procedure for confirming a diagnosis and operating safely to remove the mass.